Eagle Pharmaceuticals, Inc. to Present at September Investor Conferences
Public Company Information:
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or “the Company”) today announced that Scott Tarriff, Chief Executive Officer, and Pete Meyers, Chief Financial Officer, will present at two investor conferences in September as follows:
|Conference:||Morgan Stanley 15th Annual Global Healthcare Conference|
|Date:||Wednesday, September 13, 2017|
|Time:||8:45 a.m. Eastern Daylight Time|
|Location:||Grand Hyatt New York, New York|
|Conference:||Cantor Fitzgerald Global Healthcare Conference|
|Date:||Monday, September 25, 2017|
|Time:||9:10 a.m. Eastern Daylight Time|
|Location:||InterContinental New York Barclay Hotel, New York|
The presentations will be webcast live at the aforementioned time, and archived for 30 days thereafter, via the Company’s website at www.eagleus.com, under the Investors Section.
About Eagle Pharmaceuticals, Inc.
Eagle is a specialty pharmaceutical company focused on developing and commercializing injectable products that address the shortcomings, as identified by physicians, pharmacists and other stakeholders, of existing commercially successful injectable products. Eagle’s strategy is to utilize the FDA's 505(b)(2) regulatory pathway. Additional information is available on the Company’s website at www.eagleus.com.